Basic Information
Qsymia
62541-202
Regulatory Information
62541-202
NDA022580
C73594
December 11, 2023
USA
These highlights do not include all the information needed to use QSYMIA safely and effectively. See full prescribing information for QSYMIA. QSYMIA (phentermine and topiramate extended-release capsules), for oral use, CIV Initial U.S. Approval: 2012
HUMAN PRESCRIPTION DRUG LABEL
36
Company Information
782772263
Active Ingredients
FD&C YELLOW NO. 6
Code: H77VEI93A8
Class Code: IACT
STARCH, CORN
Code: O8232NY3SJ
Class Code: IACT
MICROCRYSTALLINE CELLULOSE
Code: OP1R32D61U
Class Code: IACT
ETHYLCELLULOSE, UNSPECIFIED
Code: 7Z8S9VYZ4B
Class Code: IACT
POVIDONE K30
Code: U725QWY32X
Class Code: IACT
GELATIN, UNSPECIFIED
Code: 2G86QN327L
Class Code: IACT
TALC
Code: 7SEV7J4R1U
Class Code: IACT
TITANIUM DIOXIDE
Code: 15FIX9V2JP
Class Code: IACT
FD&C BLUE NO. 1
Code: H3R47K3TBD
Class Code: IACT
FD&C RED NO. 3
Code: PN2ZH5LOQY
Class Code: IACT
FD&C YELLOW NO. 5
Code: I753WB2F1M
Class Code: IACT
SUCROSE
Code: C151H8M554
Class Code: IACT
Active Moieties
PHENTERMINE
Code: C045TQL4WP
TOPIRAMATE
Code: 0H73WJJ391